维普中文期刊产品整合服务
55篇 您的检索式:作者名="Ross DM"
    题名 作者 年代 出处 被引量
1Violence against emergency de- partment workers显示文摘Gates DM Ross CS McQueen L 2006J Emerg Med2006,31,3:1
2Laparoseopic ligation of splenic artery aneurysm显示文摘Sandford RM Lloyd DM Ross Naylor A 2006Surg Laparosc2006,16,:1
3Response of latent syphilis or neurosyphilis to ceftriaxone therapy in persons infected with humaninmunodeficiency virus显示文摘 Ross PG M(u)(t)her DM 1992Am J Med1992,93,:1
4l Response of latent syphilis or neurosyphilis to ceftriaxone therapy in persons infected with human immunodeficiency virus显示文摘Dowell ME Ross PG Musher DM 1992Am J Med1992,93,:1
5Moving treatment-free remission into mainstream clinical practice in CML 显示文摘Hughes TP Ross DM 2016Blood2016,24,:1
6Relationship os leukoaraiosis to cognitive decline and cognitive aging显示文摘Ross ED Hansel SL Orbelo DM 0,,02:1
7Complex home care: Part 2- family annual income, insurance premium, and out-of-pocket expenses 显示文摘Piamjariyakul U Yadrich DM Ross VM 2010Nursing Economic2010,28,5:1
8Relationship of leukoaraio- sis to cognitive decline and cognitive aging显示文摘Ross ED Hansel SL Orbelo DM 2005Cogn Behav Neu- rol2005,18,2:1
9Intention to Use Condoms Among Three Low-income, Urban African American Subgroups: Cocaine Users, Noncocaine Drug Users and Non-drug Users显示文摘Ross L Kohler CL Grimley DM 2003Urban Health2003,80,1:1
10Chickenpox increasingly affects pre- school children显示文摘Ross AM Fleming DM 2000Commun Dis Public Health2000,3,3:1
11Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element显示文摘Ignar-Trowbridge DM Teng CT Ross KA 0,,08:1
12The use of Campath in severe peripheral ulcerative keratitis associated with Wegener' s granulomatosis 显示文摘Wertheim MS Ross AH Tole DM 2006Eye2006,20,12:1
13How I determine if and when to recom- mend stopping tyrosinekinase inhibitor treatment for chronic myeloid leukaemia显示文摘Ross DM Hughes TP 2014British Journal of Haematology2014,166,1:1
14Early molecular response and female sex strongly predict stable unde- tectable BCR-ABL1, the criteria for imatinib discontinua- tion in patients with CML显示文摘Branford S Yeung DT Ross DM 2013Blood2013,121,19:1
15Safety and efficacy ofimatinib cessation for CML patients with stable undetectablcminimalresidual disease: results from the TWISTER study显示文摘Ross DM Branford S Seymour JF 2013Blood2013,122,:1
16Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study显示文摘Ross DM Branford S Seymour JF 2013Blood2013,122,:1
17Relationship of leu-koaraiosis to cognitive decline and cognitive aging显示文摘ROSS ED HANSEL SL ORBELO DM 2005Cogn Be- hav Neurol2005,18,:1
18Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCR显示文摘Ross DM Branford S Seymour JF 0,,:1
19Response of la- tent syphilis or neurosyphilis to ceftriaxone therapy in per- sons infected with human immunodeficiency virus 显示文摘Dowell ME Ross PG Musher DM 1992Am J Med1992,93,5:1
20Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCR显示文摘Ross DM Branford S Seymour JF 0,,:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费